Ethacrynic acid and furosemide

作者: Kwan Eun Kim , Gaddo Onesti , John H. Moyer , Charles Swartz

DOI: 10.1016/0002-9149(71)90438-3

关键词:

摘要: Abstract Ethacrynic acid and furosemide are the most potent diuretic agents currently available. Although evidence for a proximal tubular site of action is conflicting, main both inhibition sodium reabsorption along ascending loop Henle. Acute administration ethacrynic may produce transient slight increase in glomerular filtration rate renal plasma flow, which followed by decrease flow with diuresis dehydration. In patients who do not have congestive heart failure, acute either drug results volume, central venous pressure cardiac index, an arteriovenous oxygen differences. severe volume fall, but index increases difference narrows. Both drugs rapid short duration wide steep dose-response curves. Therefore, can be used mild to failure or fluid retention. also effective despite presence hypoalbuminemia, acid-base electrolyte imbalance low rate. refractoriness agent unusual absence failure. Neither has been widely antihypertensive therapy. No marked potency from that standard thiazide noted. especially useful those hypertension concomitant this group they help maintain adequate urinary output potentiate other drugs. Despite drugs, side effects relatively infrequent. However, close monitoring response, status recommended.

参考文章(104)
P.M. Dalal, P.M. Shah, S.C. Sheth, C.K. Deshpande, CEREBRAL EMBOLISM The Lancet. ,vol. 285, pp. 61- 64 ,(1965) , 10.1016/S0140-6736(65)91651-X
Lauwers L, Clinical experience with a new diuretic: ethacrinic acid. Acta Cardiologica. ,vol. 21, pp. 79- 89 ,(1966)
Robert A. Ulstrom, David M. Brown, Alfred F. Michael, John W. Reynolds, The use and mode of action of ethacrynic acid in nephrogenic diabetes insipidus. Pediatrics. ,vol. 37, pp. 447- 455 ,(1966)
George E. Schreiner, John F. Maher, G.W. Schmitt, Ethacrynic acid enhanced bromuresis: a comparison with peritoneal and hemodialysis. Journal of Laboratory and Clinical Medicine. ,vol. 68, pp. 913- 922 ,(1966) , 10.5555/URI:PII:0022214366900370
Horace F. Russo, Joan K. Michaelson, John E. Baer, Karl H. Beyer, RENOTROPIC CHARACTERISTICS OF ETHACRYNIC ACID: A PHENOXYACETIC SALURETIC-DIURETIC AGENT Journal of Pharmacology and Experimental Therapeutics. ,vol. 147, pp. 1- 22 ,(1965)
Donald W. Seldin, Garabed Eknoyan, Wadi N. Suki, Floyd C. Rector, LOCALIZATION OF DIURETIC ACTION FROM THE PATTERN OF WATER AND ELECTROLYTE EXCRETION Annals of the New York Academy of Sciences. ,vol. 139, pp. 328- 343 ,(1966) , 10.1111/J.1749-6632.1966.TB41207.X
Albert N. Brest, Gaddo Onesti, Robert Seller, Osvaldo Ramirez, Charles Heider, John H. Moyer, PHARMACODYNAMIC EFFECTS OF A NEW DIURETIC DRUG, ETHACRYNIC ACID. American Journal of Cardiology. ,vol. 16, pp. 99- 105 ,(1965) , 10.1016/0002-9149(65)90013-5
MICHAEL DAVIDOV, LILLIAN GAVRILOVICH, WILLIAM MROCZEK, FRANK A. FINNERTY, Relation of Extracellular Fluid Volume to Arterial Pressure during Drug-Induced Saluresis Circulation. ,vol. 40, pp. 349- 355 ,(1969) , 10.1161/01.CIR.40.3.349
F. C. Reubi, CLINICAL USE OF FUROSEMIDE Annals of the New York Academy of Sciences. ,vol. 139, pp. 433- 442 ,(1966) , 10.1111/J.1749-6632.1966.TB41217.X
JACOB ZATUCHNI, The diuretic effects of intravenously administered ethacrynic acid. The American Journal of the Medical Sciences. ,vol. 252, pp. 162- 170 ,(1966) , 10.1097/00000441-196608000-00005